BioCentury | Apr 4, 2020
Product Development

COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more

...Serological, PCR tests continue rolling out Starting April 6, Eurofins Scientific S.E. (Euronext:ERF), via its Boston Heart Diagnostics...
BioCentury | Jun 4, 2012
Company News

Boston Heart Diagnostics sales and marketing update

...1B1 (SLCO1B1; OATP2 ) gene that is associated with an increased risk of statin-induced myopathy. Boston Heart Diagnostics Corp....
BioCentury | Sep 27, 2010
Company News

Boston Heart Lab management update

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Hired: Susan Hertzberg as CEO and a director, formerly president and CEO of Ipsogen Inc., a division of Ipsogen S.A. ; she replaces Wolfgang Daum, who...
BioCentury | Sep 27, 2010
Company News

Boston Heart Lab board of directors update

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Appointed: Jeff Crisan, managing director at Bain Capital Ventures LLC; and Alice Limkakeng, principal at Bain Capital Ventures LLC WIR Staff Diagnostic...
BioCentury | Sep 27, 2010
Financial News

Boston Heart Lab completes venture financing

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Date completed: 9/21/10 Type: Venture financing Raised: $10 million Investor: Bain Capital Note: The company also disclosed that its prior two ventures rounds were under $3...
Items per page:
1 - 5 of 5
BioCentury | Apr 4, 2020
Product Development

COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more

...Serological, PCR tests continue rolling out Starting April 6, Eurofins Scientific S.E. (Euronext:ERF), via its Boston Heart Diagnostics...
BioCentury | Jun 4, 2012
Company News

Boston Heart Diagnostics sales and marketing update

...1B1 (SLCO1B1; OATP2 ) gene that is associated with an increased risk of statin-induced myopathy. Boston Heart Diagnostics Corp....
BioCentury | Sep 27, 2010
Company News

Boston Heart Lab management update

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Hired: Susan Hertzberg as CEO and a director, formerly president and CEO of Ipsogen Inc., a division of Ipsogen S.A. ; she replaces Wolfgang Daum, who...
BioCentury | Sep 27, 2010
Company News

Boston Heart Lab board of directors update

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Appointed: Jeff Crisan, managing director at Bain Capital Ventures LLC; and Alice Limkakeng, principal at Bain Capital Ventures LLC WIR Staff Diagnostic...
BioCentury | Sep 27, 2010
Financial News

Boston Heart Lab completes venture financing

Boston Heart Lab Corp. , Framingham, Mass. Business: Diagnostic, Pharmacogenetics Date completed: 9/21/10 Type: Venture financing Raised: $10 million Investor: Bain Capital Note: The company also disclosed that its prior two ventures rounds were under $3...
Items per page:
1 - 5 of 5